GlassScriptPhysician profile
Dexter Wayne Love
NPI 1366583270
$2,694.70
in general payments reported to CMS, 2019-2025
12 companies · $13.52 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,193 · 2020: $824 · 2021: $65.92 · 2022: $59.09 · 2024: $539 · 2025: $13.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $1,543.30 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $963.25 | 2020-2024 | Persona |
| Depuy Synthes Sales INC. | $33.10 | 2019 | |
| Neotract INC. | $24.75 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $23.46 | 2024 | |
| Smith+Nephew, INC. | $19.35 | 2019 | |
| Intercept Pharmaceuticals, INC. | $16.62 | 2021 | |
| Kci USA, INC. | $16.29 | 2020 | |
| 180 Medical, INC. | $16.21 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.57 | 2019 | |
| Amgen INC. | $13.52 | 2025 | Krystexxa |
| Pacira Therapeutics, INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dexter Love listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.